Gemigliptin L-tartrate Sesquihydrate

吉格列汀酒石酸盐

Report date: 2026/02/11 20:01:36
NME

Base Information

Drug NameGemigliptin L-tartrate Sesquihydrate
Drug Alias NameGemigliptin tartrate sesquihydrate吉格列汀酒石酸锑GemigloZemigloLC-150444 +[6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsFastingDiabetes Mellitus, Type 2Hepatic Insufficiency
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2012/06/27
Country/TerritoryThailandGermanySouth Korea +[4
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLg Chemical Ltd
Active IndicationsFastingDiabetes Mellitus, Type 2
Inactive IndicationsHepatic Insufficiency

Other Information

ATC CodeA10BH06